Hologic (HOLX) Stock Forecast & Price Target

Compare

1,004 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HOLX Analyst Ratings

Hold

1 Buy

11 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Hologic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HOLX Stock 12 Month Forecast

Average Price Target

$77.56

▲(4.11% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Hologic in the last 3 months. The average price target is $77.56 with a high forecast of $79.00 and a low forecast of $76.00. The average price target represents a 4.11% change from the last price of $74.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"56":"$56","62":"$62","68":"$68","74":"$74","80":"$80"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$79.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$77.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$76.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[56,62,68,74,80],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.84,75.16,75.48,75.8,76.12,76.44,76.76,77.08,77.4,77.72,78.04,78.36,78.68,{"y":79,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.84,75.04923076923077,75.25846153846155,75.46769230769232,75.67692307692307,75.88615384615385,76.09538461538462,76.30461538461539,76.51384615384616,76.72307692307693,76.93230769230769,77.14153846153846,77.35076923076923,{"y":77.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.84,74.92923076923077,75.01846153846154,75.1076923076923,75.19692307692308,75.28615384615385,75.37538461538462,75.46461538461539,75.55384615384615,75.64307692307692,75.7323076923077,75.82153846153847,75.91076923076923,{"y":76,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":79,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.14,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.39,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.38,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.28,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.33,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.16,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.61,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.91,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$79.00

Average Price Target$77.56

Lowest Price Target$76.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Mason Carrico

Stephens

$76

Hold

2.01%

Upside

Reiterated

12/03/25

Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Acadia Healthcare (NASDAQ: ACHC) and Azenta (NASDAQ: AZTA)

Navann Ty

Exane BNP Paribas

$79

Hold

6.04%

Upside

Downgraded

11/21/25

Hologic downgraded to Neutral from Outperform at BNP Paribas ExaneHologic downgraded to Neutral from Outperform at BNP Paribas Exane

Ryan Zimmerman

BTIG

Hold

―

Reiterated

11/11/25

BTIG Sticks to Their Hold Rating for Hologic (HOLX)

Patrick Wood

Morgan Stanley

$69→$76

Hold

2.01%

Upside

Reiterated

11/10/25

Hologic price target raised to $76 from $69 at Morgan StanleyHologic price target raised to $76 from $69 at Morgan Stanley

Andrew Brackmann

William Blair

Hold

―

Reiterated

11/07/25

Cautious Hold Rating for Hologic Amid Strong Q4 Results and Future Uncertainties

Liza Garcia

UBS

$70→$76

Hold

2.01%

Upside

Reiterated

11/05/25

UBS Sticks to Its Hold Rating for Hologic (HOLX)

Michael Matson

Needham

Hold

―

Assigned

11/04/25

Hologic's Mixed Performance and Acquisition Uncertainty Lead to Hold Rating

Anthony Petrone

Mizuho Securities

$75→$78

Hold

4.70%

Upside

Downgraded

10/23/25

Hologic downgraded to Neutral from Outperform at MizuhoHologic downgraded to Neutral from Outperform at Mizuho

Puneet Souda

Leerink Partners

$70→$78

Hold

4.70%

Upside

Reiterated

10/22/25

Hold Rating on Hologic Amid Acquisition by Blackstone and TPG: Limited Impact on Diagnostics Sector

Andrew Cooper

Raymond James

$79

Hold

6.04%

Upside

Downgraded

10/22/25

Hologic downgraded to Market Perform from Outperform at Raymond JamesHologic downgraded to Market Perform from Outperform at Raymond James

Casey Woodring

J.P. Morgan

$80→$78

Hold

4.70%

Upside

Downgraded

10/21/25

Hologic downgraded to Neutral from Overweight at JPMorganHologic downgraded to Neutral from Overweight at JPMorgan

Vijay Kumar

Evercore ISI

$69→$78

Buy

4.70%

Upside

Upgraded

10/07/25

Hologic upgraded to Outperform from In Line at Evercore ISIHologic upgraded to Outperform from In Line at Evercore ISI

Conor McNamara

RBC Capital

$87→$94

Buy

26.17%

Upside

Reiterated

09/02/25

Hologic (HOLX) Gets a Buy from RBC Capital

David Toung

Argus Research

$80

Buy

7.38%

Upside

Upgraded

08/18/25

Hologic upgraded to Buy from Hold at ArgusHologic upgraded to Buy from Hold at Argus

Michael Ryskin

Bank of America Securities

$64→$70

Hold

-6.04%

Downside

Reiterated

07/18/25

Bank of America Securities Sticks to Their Hold Rating for Hologic (HOLX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Mason Carrico

Stephens

$76

Hold

2.01%

Upside

Reiterated

12/03/25

Analysts Offer Insights on Healthcare Companies: Hologic (NASDAQ: HOLX), Acadia Healthcare (NASDAQ: ACHC) and Azenta (NASDAQ: AZTA)

Navann Ty

Exane BNP Paribas

$79

Hold

6.04%

Upside

Downgraded

11/21/25

Hologic downgraded to Neutral from Outperform at BNP Paribas ExaneHologic downgraded to Neutral from Outperform at BNP Paribas Exane

Ryan Zimmerman

BTIG

Hold

―

Reiterated

11/11/25

BTIG Sticks to Their Hold Rating for Hologic (HOLX)

Patrick Wood

Morgan Stanley

$69→$76

Hold

2.01%

Upside

Reiterated

11/10/25

Hologic price target raised to $76 from $69 at Morgan StanleyHologic price target raised to $76 from $69 at Morgan Stanley

Andrew Brackmann

William Blair

Hold

―

Reiterated

11/07/25

Cautious Hold Rating for Hologic Amid Strong Q4 Results and Future Uncertainties

Liza Garcia

UBS

$70→$76

Hold

2.01%

Upside

Reiterated

11/05/25

UBS Sticks to Its Hold Rating for Hologic (HOLX)

Michael Matson

Needham

Hold

―

Assigned

11/04/25

Hologic's Mixed Performance and Acquisition Uncertainty Lead to Hold Rating

Anthony Petrone

Mizuho Securities

$75→$78

Hold

4.70%

Upside

Downgraded

10/23/25

Hologic downgraded to Neutral from Outperform at MizuhoHologic downgraded to Neutral from Outperform at Mizuho

Puneet Souda

Leerink Partners

$70→$78

Hold

4.70%

Upside

Reiterated

10/22/25

Hold Rating on Hologic Amid Acquisition by Blackstone and TPG: Limited Impact on Diagnostics Sector

Andrew Cooper

Raymond James

$79

Hold

6.04%

Upside

Downgraded

10/22/25

Hologic downgraded to Market Perform from Outperform at Raymond JamesHologic downgraded to Market Perform from Outperform at Raymond James

Casey Woodring

J.P. Morgan

$80→$78

Hold

4.70%

Upside

Downgraded

10/21/25

Hologic downgraded to Neutral from Overweight at JPMorganHologic downgraded to Neutral from Overweight at JPMorgan

Vijay Kumar

Evercore ISI

$69→$78

Buy

4.70%

Upside

Upgraded

10/07/25

Hologic upgraded to Outperform from In Line at Evercore ISIHologic upgraded to Outperform from In Line at Evercore ISI

Conor McNamara

RBC Capital

$87→$94

Buy

26.17%

Upside

Reiterated

09/02/25

Hologic (HOLX) Gets a Buy from RBC Capital

David Toung

Argus Research

$80

Buy

7.38%

Upside

Upgraded

08/18/25

Hologic upgraded to Buy from Hold at ArgusHologic upgraded to Buy from Hold at Argus

Michael Ryskin

Bank of America Securities

$64→$70

Hold

-6.04%

Downside

Reiterated

07/18/25

Bank of America Securities Sticks to Their Hold Rating for Hologic (HOLX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hologic

1 Month

xxx

Success Rate

7/9 ratings generated profit

Average Return

+3.81%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 77.78% of your transactions generating a profit, with an average return of +3.81% per trade.

3 Months

xxx

Success Rate

6/9 ratings generated profit

Average Return

+2.67%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.67% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

7/9 ratings generated profit

Average Return

+19.38%

upgraded a buy rating 3 months ago

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +19.38% per trade.

2 Years

xxx

Success Rate

9/9 ratings generated profit

Average Return

+25.36%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.36% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HOLX Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HOLX has received 1 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. HOLX average Analyst price target in the past 3 months is 77.56.

Each month's total comprises the sum of three months' worth of ratings.

HOLX Financial Forecast

HOLX Earnings Forecast

Next quarter’s earnings estimate for HOLX is $1.09 with a range of $1.02 to $1.18. The previous quarter’s EPS was $1.13. HOLX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year HOLX has Performed in-line its overall industry.

HOLX Sales Forecast

Next quarter’s sales forecast for HOLX is $1.07B with a range of $1.05B to $1.09B. The previous quarter’s sales results were $1.05B. HOLX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year HOLX has Performed in-line its overall industry.

HOLX Stock Forecast FAQ

What is HOLX’s average 12-month price target, according to analysts?

Based on analyst ratings, Hologic’s 12-month average price target is 77.56.

What is HOLX’s upside potential, based on the analysts’ average price target?

Hologic has 4.11% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HOLX a Buy, Sell or Hold?

Hologic has a consensus rating of Hold which is based on 1 buy ratings, 11 hold ratings and 0 sell ratings.

What is Hologic’s price target?

The average price target for Hologic is 77.56. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $79.00 ,the lowest forecast is $76.00. The average price target represents 4.11% Increase from the current price of $74.5.

What do analysts say about Hologic?

Hologic’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of HOLX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Hologic (HOLX) Stock Forecast & Price Target

HOLX Analyst Ratings

HOLX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Hologic

HOLX Analyst Recommendation Trends

HOLX Financial Forecast

HOLX Earnings Forecast

HOLX Sales Forecast

HOLX Stock Forecast FAQ

Detailed List of Analyst Forecasts